norfloxacin has been researched along with aspartic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Deguchi, T; Fukuda, H; Ishihara, S; Kawada, Y; Yasuda, M; Yokoi, S | 1 |
| Hattori, M; Higuchi, T; Hipolito, CJ; Ishitani, R; Ito, K; Kato, HE; Katoh, T; Kumazaki, K; Kuroda, T; Maturana, AD; Nureki, O; Suga, H; Tanaka, Y; Tsukazaki, T | 1 |
| Ramana, J | 1 |
4 other study(ies) available for norfloxacin and aspartic acid
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
Topics: Anti-Infective Agents; Aspartic Acid; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Genes, Bacterial; Glutamic Acid; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin; Selection, Genetic; Serine | 2000 |
Structural basis for the drug extrusion mechanism by a MATE multidrug transporter.
Topics: Amino Acid Sequence; Antiporters; Apoproteins; Archaeal Proteins; Aspartic Acid; Crystallography, X-Ray; DNA Mutational Analysis; Macrocyclic Compounds; Models, Molecular; Molecular Sequence Data; Norfloxacin; Peptides; Protein Conformation; Protons; Pyrococcus furiosus; Structure-Activity Relationship; Sulfides | 2013 |
Structural Insights into the Fluoroquinolone Resistance Mechanism of Shigella flexneri DNA Gyrase and Topoisomerase IV.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Aspartic Acid; Binding Sites; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Gene Expression; Kinetics; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutation; Norfloxacin; Protein Binding; Serine; Shigella flexneri; Thermodynamics | 2016 |